Sensitivity of cardiac carnitine palmitoyltransferase to malonyl-CoA is regulated by leptin: Similarities with a model of endogenous hyperleptinemia

Endocrinology

Volumn 151, Issue 3, 2010, Pages 1010-1018

  Guzmán Ruiz, Rocío ^a   Somoza, Beatriz ^a   Gil Ortega, Marta ^a   Merino, Beatriz ^a   Cano, Victoria ^a   Attané, Camille ^b   Castan Laurell, Isabelle ^b   Valet, Philippe ^b   Fernández Alfonso, María S ^c   Ruiz Gayo, Mariano ^a  

^a UNIVERSIDAD SAN PABLO CEU   (Spain)

^b INSERM   (France)

^c INSTITUTO PLURIDISCIPLINAR   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CARNITINE PALMITOYLTRANSFERASE; FATTY ACID; LEPTIN; MALONYL COENZYME A; PROTEIN KINASE B; STAT3 PROTEIN; TRIACYLGLYCEROL; TRICIRIBINE;

ACUTE DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CARDIAC STEATOSIS; CHRONIC DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; ENZYME REGULATION; FATTY ACID OXIDATION; HEART; HEART WEIGHT; HYPERLEPTINEMIA; IC 50; LIPID DIET; MALE; MITOCHONDRION; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN PHOSPHORYLATION; SENSITIVITY ANALYSIS; STEATOSIS;

ANIMALS; CARNITINE O-PALMITOYLTRANSFERASE; DIETARY FATS; DISEASE MODELS, ANIMAL; HEART DISEASES; LEPTIN; LIPID METABOLISM; MALE; MALONYL COENZYME A; MICE; MICE, INBRED C57BL; MYOCARDIUM; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RIBONUCLEOSIDES; STAT3 TRANSCRIPTION FACTOR; TRIGLYCERIDES;

EID: 77149120129     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2009-1170     Document Type: Article

References (39)

1. Lopaschuk GD, Belke DD, Gamble J, Itoi T, Schönekess B 1994 Regulation of fatty acid oxidation in the mammalian heart in health and disease. Biochem Biophys Acta 1213:263-276
2. Lopaschuk GD, Folmes CD, Stanley WC 2007 Cardiac energy metabolism in obesity. Circ Res 101:335-347
3. Stanley WC, Chandler MP 2002 Energy metabolism in the normal and failing heart: potential for therapeutic interventions. Heart Failure Rev 7:115-130
4. Stanley WC, Recchia FA, Lopaschuk GD 2005 Myocardial substrate metabolism in the normal and failing heart. Physiol Rev 85: 1093-1129
5. Kim JY, Koves TR, Yu GS, Gulick T, Cortright RN, Dohm GL, Muoio DM 2002 Evidence of a malonyl-CoA-insensitive carnitine palmitoyltransferase I activity in red skeletal muscle. Am J Physiol Endocrinol Metab 282:E1014-E1022
6. Power GW, Newsholme EA 1997 Dietary fatty acids influence the activity and metabolic control of mitochondrial carnitine palmitoyltransferase I in rat heart and skeletal muscle. J Nutr 127:2142-2150
7. Weis BC, Essert V, Foster DW, McGarry JD 1994 Rat heart expresses two forms of mitochondrial carnitine palmitoyltransferase I. J Biol Chem 269:18712-18715
8. Folmes CD, Lopaschuk GD 2007 Role of malonyl-CoA in heart disease and the hypothalamic control of obesity. Cardiovasc Res 73:278-287
9. Kerbey AL, Randle PJ, Cooper RH, Whitehouse S, Pask HT, Denton RM 1976 Regulation of pyruvate dehydrogenase in rat heart. Biochem J 154:327-348
10. Dolinsky VW, Dyck JR 2006 Role of AMP-activated protein kinase in healthy and diseased hearts. Am J Physiol Heart Circ Physiol 291:H2557-H2569
11. Atkinson LL, Kozak R, Kelly SE, Onay-Besikci A, Russsel JC, Lopaschuk GD 2003 Potential mechanisms and consequences of cardiac triacylglycerol accumulation in insulin-resistant rats. Am J Physiol Physiol Endocrinol Metab 284:E923-E930
12. McGavock JM, Victor RG, Unger RH, Szczepaniak LS 2006 Adiposity of the heart, revisited. Ann Intern Med 144:517-524
13. Unger RH 2003 Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome. Endocrinology 144:5159-5165
14. Kovacic S, Soltys CL, Barr AJ, Shiojima I, Walsch K, Dyck JR 2003 Akt activity negatively regulates phosphorylation of AMP-activated protein kinase in the heart. J Biol Chem 278:39422-39427
15. Somoza B, Guzmán R, Cano V, Merino B, Ramos P, Díez-Fernández C, Fernández-Alfonso MS, Ruiz-Gayo M 2007 Induction of cardiac uncoupling protein-2 expression and adenosine 5′-monophosphateactivated protein kinase phosphorylation during early states of dietinduced obesity. Endocrinology 148:924-931
16. Guzmán-Ruiz R, Stucchi P, Gil-Ortega M, Merino B, Cano V, Somoza B, Fernández-Alfonso MS, Ruiz-Gayo M 2009 Adipo-hepatic flux of triacylglycerol in diet-induced obesity is coincident with leptin signalling disruption of leptin within the liver (Abstract). Obesity Facts 2:149
17. Boudina S, Sena S, O'Neill BT, Tathireddy P, Young ME, Abel ED 2005 Reduced mitochondrial oxidative capacity and increased mitochondrial uncoupling impair myocardial energetics in obesity. Circulation 112:2686-2695
18. Rodnick KJ, Sidell BD 1994 Cold acclimation increases carnitine palmitoyltransferase I activity in oxidative muscle of stripped bass. Am J Physiol 266:R405-R412
19. Shein NA, Tsenter J, Alexandrovich AG, Horowitz M, Shohami E 2007 Akt phosphorylation is required for heat acclimation-induced neuroprotection. J Neurochem 103:1523-1529
20. Elmquist JK, Ahima RS, Elias CF, Flier JS, Saper CB 1998 Leptin activates distinct projections from the dorsomedial and ventromedial hypothalamic nuclei. Proc Natl Acad Sci USA 95:741-746
21. Morisco C, Condorelli G, Trimarco V, Bellis A, Marrone C, Condorelli G, Sadoshima J, Trimarco B 2005 Akt mediates the cross-talk between β-adrenergic and insulin receptors in neonatal cardiomyocytes. Circ Res 96:180-188
22. Minokoshi Y, Kim YB, Peroni OD, Fryer LG, Müller C, Carling D, Kahn BB 2002 Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 415:339-343
23. Yang L, Dan HC, Sun M, Liu Q, Sun XM, Feldman RI, Hamilton AD, Polokoff M, Nicosia SV, Herlyn M, Sebti SM, Cheng JQ 2004 Akt/protein kinase B signaling inhibitor-2, a selective small molecule inhibitor of Akt signaling with antitumor activity in cancer cells overexpressing Akt. Cancer Res 64:4394-4399
24. Atkinson LL, Fischer MA, Lopaschuk GD 2002 Leptin activates cardiac fatty acid oxidation independent of changes in the AMPactivated protein kinase-acetyl-CoA carboxylase-malonyl-CoA axis. J Biol Chem 277:29424-29430
25. Velasco G, Geelen MJ, Gómez del Pulgar T, Guzmán M 1998 Malonyl-CoA-independent acute control of hepatic carnitine palmitoyltransferase I activity. J Biol Chem 273:21497-21504
26. Velasco G, Gómez del Pulgar T, Carling D, Guzmán M 1998 Evidence that the AMP-activated protein kinase stimulates rat liver carnitine palmitoyltransferase I by phosphorylating cytoskeletal components. FEBS Lett 439:317-320
27. Kerner J, Distler AM, Minkler P, Parland W, Peterman SM, Hoppel CL2004 Phosphorylation of rat liver mitochondrial carnitine palmitoyltransferase-I. J Biol Chem 279:41104-41113
28. Wright JJ, Kim J, Buchanan J, Boudina S, Sena S, Bakirtzi K, Ilkun O, Theobald HA, Cooksey RC, Kandror KV, Abel ED 2009 Mechanisms for increased myocardial fatty acid utilization following short-term high-fat diet. Cardiovasc Res 82:351-360
29. Lee Y, Wang MY, Kakuma T, Wang ZW, Babcock E, McCorkle K, Higa M, Zhou YT, Unger RH 2001 Liporegulation in diet-induced obesity. J Biol Chem 276:5629-5635
30. Arad M, Seidman CE, Seidman JG 2007 AMP-activated protein kinase in the heart: role during health and disease. Circ Res 100:474-488
31. Randle PJ, Garland PB, Hales CN, Newsholme EA 1963 The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 13:785-789
32. Luptak I, Shen M, He H, Hirshman MF, Musi N, Goodyear LJ, Yan J, Wakimoto H, Morita H, Arad M, Seidman CE, Seidman JG, Ingwall JS, Balschi JA, Tian R 2007 Aberrant activation of AMPactivated protein kinase remodels metabolic network in favor of cardiac glycogen storage. J Clin Invest 117:1432-1439
33. Carroll R, Carley AN, Dyck JR, Severson DL 2005 Metabolic effects of insulin on cardiomyocytes from control and diabetic db/db mouse hearts. Am J Physiol Endocrinol Metab 288:E900-E906
34. Tschöp MH, Hui DY, Horvath TL 2007 Diet-induced leptin resistance: the heart of the matter. Endocrinology 148:921-923
35. Dyck JR, Cheng JF, Stanley WC, Barr R, Chandler MP, Brown S, Wallace D, Arrhenius T, Harmon C, Yang G, Nadzan AM, Lopaschuk GD 2004 Malonyl coenzyme A decarboxylase inhibition protects the ischemic heart by inhibiting fatty acid oxidation and stimulation glucose oxidation. Circ Res 94:e78-e84
36. Huss JM, Kelly DP 2005 Mitochondrial energy metabolism in heart failure: a question of balance. J Clin Invest 115:547-555
37. Selvetella G, Lembo G 2005 Mechanisms of cardiac hypertrophy. Heart Failure Clin 1:263-273
38. Dyck JR, Lopaschuk GD 2006 AMPK alterations in cardiac physiology and pathology: enemy or ally? J Physiol 574:95-112
39. Ussher JR, Lopaschuk GD 2008 The malonyl-CoA axis as a potential target for treating ischaemic heart disease. Cardiovasc Res 79: 259-268